Din webbläsare stödjs inte längre!

Din webbläsare, Internet Explorer, är för gammal och stödjs inte längre av detta verktyg. Vänligen uppdatera din webbläsare till Microsoft Edge, Google Chrome eller Mozilla Firefox.

22 mars 2023 kl. 13.00–15.30
7A Posthuset, Vasagatan 28, Stockholm + digital
Anordnas av: Amgen, Astra Zeneca, Bayer, Novartis and Novo Nordisk with the support from Efpia and in collaboration with Lif

Healthier Hearts: Why boosting cardiovascular health policy is critical for Europe

Cardiovascular disease (CVD) is the leading cause of death in Europe, despite medical advances contributing to a drop in overall mortality over the past decades. While CVD accounts for about 20 % of all premature deaths, the World Health Organization estimates that about 80 % of CVDs are preventable. 

A key question to maintain future sustainable health care systems will be how to reduce premature and preventable deaths caused by cardiovascular diseases.

In the context of the Swedish Presidency of the Council of the European Union, this event will provide a platform for dialogue and best practice sharing on how to tackle cardiovascular disease in Europe and identify key policy actions on EU and member state-level.

Invitation as pdf


Register for the event